RxDoctor Payments Data

Ross Wiedemann, MD

Psychiatry · Bozeman, MTNPI 1437713385

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Alkermes, Inc. at 45.7% of the total. Reporting peaked in 2021 at $577 and has fallen 96.7% since, to $19 in 2024.

$1,213in general payments, 2019–2025

Across 36 payments — averaging $33.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$554
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$294
  • Teva Pharmaceuticals USA, Inc.$145
  • Otsuka America Pharmaceutical, Inc.$141
  • Lundbeck LLC$30
  • AbbVie$27
  • plus $22 from 1 others

What the payments were for

  • Food & beverage$1,213100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,213 in reported general payments places this provider in the 85th percentile of 82 psychiatry providers in Montana.

See all psychiatry providers in Montana

Medicare billing

Part B allowed, 2024
$21,455
Medicare patients
44
Services billed
191

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lurasidone Hcl25$12,742
Olanzapine19$1,766
Vilazodone Hcl13$1,291
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine13$1,219
Duloxetine Hcl31$813
Lamotrigine64$728
Bupropion XlBupropion Hcl50$617
Gabapentin55$536
Liothyronine Sodium19$463
Aripiprazole30$434
Clonazepam48$429
Buspirone Hcl40$425
Guanfacine Hcl ErGuanfacine Hcl22$376
Mirtazapine46$312
Trazodone Hcl38$273

Paid to pharmacies, not to this prescriber.

Other psychiatry in Bozeman

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →